Obesity Medications
JAMA Clinical Reviews
00:00
Comparing Terzepatide to Semaglutide and Future of Weight Loss Drugs
This chapter explores the weight loss effectiveness of terzepatide, a dual agonist, when compared to semaglutide. It highlights the potential of dual agonists and Triagonists in enhancing weight loss outcomes, along with the development of oral small molecules mimicking the effects of GOP-1 for future weight loss drug advancements.
Transcript
Play full episode
